5-5 Fused Ring C5a Inhibitors for Autoimmune Disease
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for autoimmune and inflammatory diseases, such as rheumatoid arthritis and sepsis, are inadequate due to the lack of effective modulators for the C5a receptor, which plays a crucial role in inflammation and tissue injury.
Innovation Solution
Development of small organic molecule modulators, including antagonists and partial agonists, that target the C5a receptor to inhibit pathogenic events like chemotaxis and anaphylatoxin activity, thereby reducing inflammation and tissue damage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for autoimmune and inflammatory diseases are used, then existing therapeutic options are available, but treatment effectiveness is inadequate due to lack of effective C5a receptor modulators
Solution Approach 1:
The invention segments the broad class of C5a receptor modulators into distinct chemical series (e.g., compounds of Formula I with specific ring structures A1, A2, A3 and their respective substituent patterns R1-R6). This segmentation allows for targeted optimization of each series to achieve effective C5a receptor antagonism while maintaining manageable complexity in development and testing
Solution Approach 2:
The invention systematically varies key molecular parameters including ring structure types (A1, A2, A3), substituent positions (R1-R6), and molecular configurations to optimize C5a receptor binding affinity and antagonistic activity. This parameter optimization enables the development of compounds with improved treatment effectiveness for autoimmune and inflammatory diseases
2Object-affected harmful factors
If C5a receptor activity is inhibited to reduce inflammation, then tissue damage is reduced, but the ability to treat diverse inflammatory conditions requires versatile modulator compounds
Solution Approach 1:
The invention develops C5a receptor modulator compounds with universal applicability across multiple inflammatory and autoimmune disease conditions including rheumatoid arthritis, lupus nephritis, and other C5a-mediated pathologies. The core molecular framework (Formula I with various ring structures) provides a versatile platform that can effectively treat diverse diseases by blocking the common C5a receptor pathway involved in all these conditions
Data Source
AI summary
The present disclosure provides, inter alia, Compounds of Formula (I) (I) or pharmaceutically acceptable salts thereof that are modulators of the C5a receptor. Also provided are pharmaceutical compositions and methods of use including the treatment of diseases or disorders involving pathologic activation from C5a and non-pharmaceutical applications.